Publication | Closed Access

Hyperthermic intraperitoneal chemotherapy (HIPEC) as adjuvant and therapeutic options for patients with advanced gastric cancer at high risk of recurrence or established peritoneal metastases: a single-centre experience

Surgical OncologyGastrointestinal OncologyAdvanced Gastric CancerMedicineHyperthermic Intraperitoneal ChemotherapySurgeryCancer TreatmentOncologyRadiation OncologyHigh Risk